
Neowick Pharmaceuticals Private Limited
About Neowick Pharmaceuticals Private Limited
Data last updated:
Neowick Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 08 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2012PTC051883. Its GSTIN is 09AAECN2636E1ZL (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ajay Kumar Mall and Poonam Mall.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 85 – D Muglaha Near St. Paul'S School Chargawan, Gorakhpur, Uttar Pradesh, India – 273409.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.87 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2,198 (net margin 0.2%) and EBITDA of ₹4,466 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years and 373% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Neowick Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address85 – D Muglaha Near St. Paul'S School Chargawan, Gorakhpur, Uttar Pradesh, India – 273409
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Neowick Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neowick Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neowick Pharmaceuticals Private Limited, buy the company report.
Financials of Neowick Pharmaceuticals Private Limited
FY 2024 filings availableNeowick Pharmaceuticals Private Limited reported revenue of ₹11.87 Lakh (up 177% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 373% over five years, including 177% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,466 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,198 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neowick Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neowick Pharmaceuticals Private Limited
Neowick Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Mall | Director | 08 Aug 2012 | 14 Years 2 Months | Current |
| Poonam Mall | Director | 08 Aug 2012 | 14 Years 2 Months | Current |
| Priyanka Singh | Director | 08 Aug 2012 | 14 Years 2 Months | Current |
| Ashutosh Kumar Singh | Director | 08 Aug 2012 | 14 Years 2 Months | Current |
Peer comparison
Neowick Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sternum Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2023) | Ayodhya, Uttar Pradesh, India | ||||
| Singulans Pharmaceuticals Private Limited | ₹11.97 Lakh (FY 2024) | 4428.0% | Lucknow, Uttar Pradesh, India | |||
| Primax Pharmaceuticals Private Limited | ₹11.89 Lakh (FY 2018) | 302.0% | Dhanbad, Jharkhand, India | |||
| Neowick Pharmaceuticals Private Limitedthis company | ₹11.87 Lakh (FY 2024) | ₹2,198 | 0.2% | 177.0% | Gorakhpur, Uttar Pradesh, India | |
| Pansofy Pharmaceuticals Private Limited | ₹11.86 Lakh (FY 2024) | -8.0% | Mahoba, Uttar Pradesh, India |
To see the full peer comparison of Neowick Pharmaceuticals Private Limited, buy the company report.
Auditor
Neowick Pharmaceuticals Private Limited is audited by GAURAV G AGRAWAL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV G AGRAWAL & CO. | FY 2017 | 014208C |
Shareholding
The shareholding of Neowick Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Neowick Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neowick Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neowick Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neowick Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECN2636E1ZL | Uttar Pradesh | Active | 07 Feb 2019 |
To see the full GST registrations and return filing status of Neowick Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neowick Pharmaceuticals Private Limited has 4 board changes on record since 2012: 4 appointments. The latest: Ajay Kumar Mall was appointed as Director on 08 Aug 2012.
Frequently asked questions
Neowick Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 08 August 2012 (14+ years old) and is registered under CIN U24233UP2012PTC051883.
Neowick Pharmaceuticals has 4 current directors:
- Ajay Kumar Mall - Director
- Poonam Mall - Director
- Priyanka Singh - Director
- Ashutosh Kumar Singh - Director
The latest financial statements of Neowick Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Neowick Pharmaceuticals is 09AAECN2636E1ZL, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Neowick Pharmaceuticals is U24233UP2012PTC051883. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neowick Pharmaceuticals was incorporated on 08 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Neowick Pharmaceuticals by revenue are Sternum Pharmaceuticals Private Limited, Singulans Pharmaceuticals Private Limited, Primax Pharmaceuticals Private Limited, Pansofy Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajay Kumar Mall was appointed as Director on 08 Aug 2012. Ashutosh Kumar Singh was appointed as Director on 08 Aug 2012. Poonam Mall was appointed as Director on 08 Aug 2012. Neowick Pharmaceuticals has 4 board changes on record in total.
The registered office of Neowick Pharmaceuticals is at 85 – D Muglaha Near St. PaulS School Chargawan, Gorakhpur, Uttar Pradesh, India – 273409.
Neowick Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Neowick Pharmaceuticals is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.

